Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP)

Management of women with epilepsy (WWE) during pregnancy requires balancing the risk of seizure recurrence against the adverse effect of anti-epileptic drugs (AED) on the women and foetus. The risk of major congenital malformations (MCMs) is relatively higher in AED exposed women (4% – 9%) as compared to the rate in the general population of women in the reproductive age in the United Kingdom (2.13%)[1] and other high income countries. . Hospital based MCM rate for unselected pregnancies in urban area in western India was 2.31% (1.71-3.10).

0